NCT06708897
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06708897
Title A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lomond Therapeutics Holdings, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Norton Cancer Institute, St. Matthews Campus RECRUITING Louisville Kentucky 40207 United States Details
University of North Carolina at Chapel Hill RECRUITING Chapel Hill North Carolina 27599 United States Details
University of Cincinnati RECRUITING Cincinnati Ohio 45221 United States Details
The Ohio State University RECRUITING Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field